CM Management’s Amgen AMGN Stock Holding History

CM Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,000	Closed	-$1.24M	–	87
2021 Q1	$1.24M	Buy	+5,000	New	+$1.19M	0.92%	41

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

CM Management's AMGN Position: Q2 2021 in Review

CM Management sold out of Amgen (AMGN) in Q2 2021, closing a stake of 5,000 shares — an estimated $1.24M sold.

CM Management first reported a position in AMGN in Q1 2021 and held it in 1 quarter. The position peaked at $1.24M in Q1 2021. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

CM Management reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
CM Management sold 5,000 Amgen shares in Q2 2021, an estimated $1.24M.
CM Management first reported a position in Amgen in Q1 2021 and held it in 1 quarter.
CM Management's Amgen position peaked at $1.24M in Q1 2021.
2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on CM Management's 13F filing for Q2 2021, filed 10 Aug 2021.